Scientific Program
Oncology
NOVEMBER 28th, 2008 – FRIDAY
NOVEMBER 28th, 2008 – FRIDAY
OPENING CEREMONY FOLLOWED BY RECEPTION (COCKTAIL)
ALL SPEAKERS (FACULTY) INVITED 7 p.m. - IN THE CONVENTION CENTER – CONVEX
Ave. Morones Prieto 1500
Monterrey, NL 64710
México
NOVEMBER 29th, 2008 – SATURDAY
NOVEMBER 30TH , 2008 - SUNDAY
Abbreviations
(A) = Adrenal cancer
(B) = Bladder cancer
CAU = American Confederation of Urology
FAU = Argentinien Federation of Urology
(K) = Kidney cancer
(P) = Prostate cancer
(Pe) = Penis cancer
SAU = Argentinien Society of Urology
SBU = Brasilian Society of Urology
SMU = Mexican Society of Urology
SUO = Uruguayan Society of Urology
(T) = Testicular cancer
(UO) = Uro-oncology (all tumors included)
Oncology
NOVEMBER 28th, 2008 – FRIDAY
| URO-ONCO I | |||
| Time | President: Anel Aragon (MX) | Duration (with discussion) |
Speakers |
| 08:30 | (K) State-of-the-art lecture Nephron-sparing surgery: when and how? | 20 | A. Souza Jr. |
| 08:50 | (K) New ablative techniques for localized RCC: what can we indicate for our patients? | 20 | M. A. Jimenez Rios |
| 09:10 | (K) SAU lecture: Treatment of (local) recurrence of kidney cancer | 20 | M. Costa |
| 09:30 | (K) What are the limits of laparoscopy for renal surgery? (K) Is there a reliable prospective randomized trial comparing open and lap. approach? | 20 | H. Manzanilla Garcia |
| 09:50 | (UO) Uro-Oncology in the childhood | 15 | A. Souza Jr. |
| 10:05 | (K) The best approaches for kidney tumor with cava thrombus? | 15 | CC Fonseca |
| 10:20 | Cases presentation and discussion | 30 | Cases by S. Metrebian Panelists: A. Souza Jr., H Manzanilla Garcia, MA Jimenez Rios, R Ackermann |
| 10:50 | Break | 30 | |
| 11:20 | President: Miguel A. Jimenez Rios (MX) Moderation: Claudio Telöken (BR) |
Duration (with discussion) |
Speakers |
| 11:20 | (T) Retroperitoneal lymphadenectomy: indications and technique | 20 | C. Telöken |
| 11:40 | (UO) Follow-up for patients with Testis, Kidney and Bladder Cancer | 20 | R. Ackermann |
| 12:00 | (Pe) New aspects of the treatment of penile cancer | 20 | R. Decia |
| 12:20 | (T, Pe) Cases presentation and discussion | 20’ | Cases by Cláudio Telöken Panelists: MJ Rios, R Decia, R Ackermann |
| 13:00 | End | ||
NOVEMBER 28th, 2008 – FRIDAY
OPENING CEREMONY FOLLOWED BY RECEPTION (COCKTAIL)
ALL SPEAKERS (FACULTY) INVITED 7 p.m. - IN THE CONVENTION CENTER – CONVEX
Ave. Morones Prieto 1500
Monterrey, NL 64710
México
NOVEMBER 29th, 2008 – SATURDAY
| URO-ONCO II | |||
| Time | President: S. Metrebian (ARG) | Duration (with discussion) |
Speakers |
| 08:30 | (B) Concepts to consider in the pathogenesis of bladder cancer. | 15 | M. Droller |
| 08:45 | (B) Fluorescence guided cystoscopy and resection: technique and results. Should we indicate it now? | 15 | M. Bendhack |
| 09:00 | (B) The use of markers and cytology in bladder cancer. | 20 | M. Droller |
| 09:20 | (B) The role of lymphadenectomy. Extended? If yes, how far? | 20 | C.C. Fonseca |
| 09:40 | (UO) State-of-the-art lecture: Medical treatment of tumors |
20 | R. Ackermann |
| 10:00 | (B) Cases presentation and discussion | 30’ | Cases by S Metrebian Panelists: CC Fonseca, M Droller, E Wiermann, R Ackermann |
| 10:30 | Break | 30 | |
| Time | KIDNEY (ADVANCED) AND PROSTATE I President: H. Chávez Ceballos (MX) Moderation: M. Seleme (BR) |
Duration (with discussion) |
Speakers |
| 11:00 | (K) State of the art: Advances in the treatment of advanced renal cell carcinoma | 20 | M. Wirth |
| 11:20 | (P) The importance of multidisciplinary teams in the treatment of complications of radical prostatectomy | 10 | L. Dabbadie |
| 11:30 | (P) Treatment of urinary incontinence after radical prostatectomy | 10 | B. Berghmans |
| 11:40 | (P) Treatment of sexual complications after radical prostatectomy | 10 | L. Dabbadie |
| 11:50 | (P) State-of-the-art lecture Robot-assisted radical prostatectomy – is it the future? | 20 | M. Wirth |
| 12:10 | (P) Are minimally invasive treatment options beyond the study phase? | 20 | M. Bendhack |
| 12:30 | (P) Discussion | 30 | HC Ceballos Panelists: B Berghmans, M Droller, M. Bendhack, M Wirth, |
| 13:00 | End | ||
NOVEMBER 30TH , 2008 - SUNDAY
| Time | URO-ONCO III - Diagnosis and Therapy of Prostate Cancer President: M. Wirth (GER) Moderation: D. Calvo (MX) |
Duration (with discussion) |
Speakers |
| 8:30 | (P) Issues and pitfalls in considering screening for prostate cancer | 20 | M. Droller |
| 8.50 | (P) Active surveillance and watchful waiting: what are they and when should be indicated? Management of incidental tumors. | 20 | G. Lopez Secchi |
| 9:10 | (UO) How to classify the risk of uro-oncologic malignancies? The risk of progression. | 25 | R. Ackermann |
| 9.35 | (P) Adjuvant treatment after curative treatment: only for high risk? | 25 | A. Mendoza Valdez |
| 10:00 | Coffee Break | 30 | |
| 10:30 | (P) Patient’s perspective: Is it possible to accept guidelines on treatment for localized disease? How would be my personal treatment choice? | 20 | S. Metrebian |
| 10:50 | (P) Management of high risk prostate cancer | 20 | M. Bendhack |
| 11:10 | (P) New perspectives in the treatment of metastatic prostate cancer | 30 | M. Wirth |
| 11:40 | (P) Discussion | 20 | A. Aragon M. Bendhack |
| 12:00 | End of the Meeting | ||
Abbreviations
(A) = Adrenal cancer
(B) = Bladder cancer
CAU = American Confederation of Urology
FAU = Argentinien Federation of Urology
(K) = Kidney cancer
(P) = Prostate cancer
(Pe) = Penis cancer
SAU = Argentinien Society of Urology
SBU = Brasilian Society of Urology
SMU = Mexican Society of Urology
SUO = Uruguayan Society of Urology
(T) = Testicular cancer
(UO) = Uro-oncology (all tumors included)
